Skip to main content

Global Antifungal Drugs Market 2019 by Manufactures: Merck & Co., Glaxo Smith Kline, Astellas Pharma, Sanofi, Abbott Laboratories and Forecast to 2023

The Antifungal Drugs Market report intends to provide cutting-edge market intelligence and help decision makers take sound investment evaluation.

Pune, India - July 15, 2019 /MarketersMedia/

Global “Antifungal Drugs Market” (2018-2023) report presents a comprehensive overview, market shares, and growth opportunities of Antifungal Drugs market by product type, application, key manufacturers and key regions and countries.

Request a Sample Copy of the Report: https://www.absolutereports.com/enquiry/request-sample/13812998

Antifungal Drugs Market Manufactures:
• Merck & Co.
• Glaxo Smith Kline
• Astellas Pharma
• Sanofi
• Abbott Laboratories
• Bayer
• Kramer Laboratories
• Novartis International AG
• Pfizer

About Antifungal Drugs:
The antifungal drugs market is projected to display a robust growth represented by a CAGR of 3.70% during 2018 – 2023.
Over the recent years, Antifungal Drugs market has been witnessing growth on account of several driving factors including growing prevalence of fungal infections such as candidiasis and aspergillosis, increasing popularity of over-the-counter drugs, and increase in availability of innovative antifungals. Moreover, increasing awareness regarding fatal antifungal diseases, growing medical spending, favorable government initiatives, public private partnership have been driving the market growth. In addition, rising geriatric population, increasing global healthcare expenditure and technological advancements in pharmaceuticals research, growing scope in developing countries with large population such as China and India is anticipated to impel the market growth of the antifungal drugs market. However, growing portfolio of antifungal generic drugs, patent expiration of innovator drugs, increasing prevalence of fungal resistance, and counterfeit drugs are expected to hinder the market performance during forecasted period.
In this research report, the market is segmented on the basis of drug class and therapeutic indications. By drug class, the azoles class antifungals are predicted to hold their dominant position in the market. By therapeutic indications, drugs use in the treatment of candidiasis are anticipated to creates their dominance in global antifungal drugs market. Amongst the regions, North America accounts for the largest regional share in the global antifungal drugs market in 2017. The largest share of North America is attributed to presence of enormous number of patient base and highly advanced medical infrastructure.

Inquire or Share Your Questions If Any before the Purchasing This Report- https://www.absolutereports.com/enquiry/pre-order-enquiry/13812998

This report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyses key emerging trends and their impact on present and future development.

Scope of the Report

Global Antifungal Drugs Market (Actual Period: 2013-2017, Forecast Period: 2018-2023)
• Antifungal Drugs Market– Size, Growth, Forecast
• Analysis By Drug Type - Azole Class Antifungal Drugs, Echinocandins Class Antifungal Drugs, Polyenes Class Antifungal Drugs,

Other Class Antifungal Drugs
• Analysis By Therapeutic Indications - Aspergillus, Dermatophytosis, Candidiasis, Other Therapeutic Indications

Regional Antifungal Drugs Market – North America, Europe, Asia Pacific, and Rest of the World (Actual Period: 2013-2017, Forecast Period: 2018-2023)
• Antifungal Drugs Market– Size, Growth, Forecast
• Analysis By Drug Type - Azole Class Antifungal Drugs, Echinocandins Class Antifungal Drugs, Polyenes Class Antifungal Drugs,

Other Class Antifungal Drugs
• Analysis By Therapeutic Indications - Aspergillus, Dermatophytosis, Candidiasis, Other Therapeutic Indications
Country Analysis – U.S., Canada, Germany, U.K, France, China, Japan, and India (Actual Period: 2013-2017, Forecast Period: 2018-2023)
• Antifungal Drugs Market– Size, Growth, Forecast
• Analysis By Drug Type - Azole Class Antifungal Drugs, Echinocandins Class Antifungal Drugs, Polyenes Class Antifungal Drugs,

Other Class Antifungal Drugs
• Analysis By Therapeutic Indications - Aspergillus, Dermatophytosis, Candidiasis, Other Therapeutic Indications

Other Report Highlights
• Market Dynamics – Drivers and Restraints.
• Market Trends.
• Porter Five Forces Analysis.
• SWOT Analysis.

Purchase this Report (Price 2400 USD for Single User License): https://www.absolutereports.com/purchase/13812998

Table of Content of Antifungal Drugs Market
1. Research Methodology

2. Executive Summary

3. Strategic Recommendations

4. Antifungal Drugs Products Outlook

5. Global: Growth and Forecast
5.1 By Value (2013-2017)
5.2 By Value (2018-2023)

6. Global Market: Segmental Analysis
6.1 Global Market Size, By Drug Class: Breakdown (%)
6.1.1 Global Market Size, By Drug Class, 2017 (%)
6.1.2 Global Market Size, By Drug Class, 2023 (%)
Continued…
8. North America Antifungal Drugs Market: An Analysis

9. Europe Antifungal Drugs Market: An Analysis

10. APAC Antifungal Drugs Market: An Analysis

11. ROW Antifungal Drugs Market: Growth and Forecast

12. Global Market Dynamics
12.1 Global Market Drivers
12.2 Global Antifungal Drugs Market Restrains
12.3 Global Market Trends

13. Porter Five Force Analysis

14. SWOT Analysis

15. Antifungal Drugs Market – Competitive Landscape

Contact Info:
Name: Ajay More
Email: Send Email
Organization: Absolute Reports
Phone: US +1424 253 0807/ UK +44 203 239 8187
Website: https://www.absolutereports.com

Source URL: https://marketersmedia.com/global-antifungal-drugs-market-2019-by-manufactures-merck-co-glaxo-smith-kline-astellas-pharma-sanofi-abbott-laboratories-and-forecast-to-2023/88896551

Source: MarketersMedia

Release ID: 88896551

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.